Summary by Futu AI
Matthew Scott Harris, Chief Medical Officer of Altimmune, Inc. [ALT], completed a series of stock transactions on February 1 and 2, 2024. Harris exercised options to acquire a total of 13,941 shares of common stock at no cost. Concurrently, he disposed of 4,133 shares to cover exercise prices or tax liabilities, with the sales priced between $9.32 and $9.88 per share, resulting in a total market value of $39,528.12. Following these transactions, Harris holds a total of 53,633 Altimmune shares directly.